对HIV-1蛋白酶抑制剂产生耐药性的发展过程。 - Suppr

Suppr

超能文献

Development of drug resistance to HIV-1 protease inhibitors.

作者信息

Ridky T, Leis J

机构信息

Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106-4935, USA.

出版信息

J Biol Chem. 1995 Dec 15;270(50):29621-3. doi: 10.1074/jbc.270.50.29621.

DOI:10.1074/jbc.270.50.29621

PMID:8530341

Abstract

摘要

相似文献

Development of drug resistance to HIV-1 protease inhibitors.对HIV-1蛋白酶抑制剂产生耐药性的发展过程。

J Biol Chem. 1995 Dec 15;270(50):29621-3. doi: 10.1074/jbc.270.50.29621.

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.1型人类免疫缺陷病毒的病毒背景在对蛋白酶抑制剂耐药性的产生中起主要作用。

Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1648-53. doi: 10.1073/pnas.93.4.1648.

Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959.1型人类免疫缺陷病毒对蛋白酶抑制剂Ro 31-8959的耐药性。

AIDS Res Hum Retroviruses. 1995 Jun;11(6):671-6. doi: 10.1089/aid.1995.11.671.

HIV proteinase inhibitors.HIV蛋白酶抑制剂。

Biochem Soc Trans. 1992 May;20(2):513-6. doi: 10.1042/bst0200513.

In vivo resistance to a human immunodeficiency virus type 1 proteinase inhibitor: mutations, kinetics, and frequencies.对人免疫缺陷病毒1型蛋白酶抑制剂的体内抗性：突变、动力学及频率

J Infect Dis. 1996 Jun;173(6):1379-87. doi: 10.1093/infdis/173.6.1379.

Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials.

Antiviral Res. 1996 Jan;29(1):95-7. doi: 10.1016/0166-3542(95)00927-2.

Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuran.基于结构的HIV-1蛋白酶抑制剂设计：用稠合双四氢呋喃取代两个酰胺和一个10π-芳族体系。

J Med Chem. 1994 Aug 5;37(16):2506-8. doi: 10.1021/jm00042a002.

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.

Biochemistry. 1995 Jul 25;34(29):9282-7. doi: 10.1021/bi00029a002.

The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors.

J Med Chem. 1994 Apr 15;37(8):1177-88. doi: 10.1021/jm00034a016.

Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase.

Acta Virol. 1994 Oct;38(5):297-8.

引用本文的文献

Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds.抗逆转录病毒治疗 HIV-2 感染：现有药物、耐药途径和有前途的新化合物。

Int J Mol Sci. 2023 Mar 21;24(6):5905. doi: 10.3390/ijms24065905.

NMR and MD studies combined to elucidate inhibitor and water interactions of HIV-1 protease and their modulations with resistance mutations.NMR 和 MD 研究联合阐明了 HIV-1 蛋白酶抑制剂和水的相互作用及其与耐药突变的调节。

J Biomol NMR. 2019 Jul;73(6-7):365-374. doi: 10.1007/s10858-019-00260-6. Epub 2019 Jun 26.

Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System.使用HIV-2模块化系统对逆转录病毒蛋白酶抑制剂进行抑制谱分析。

Viruses. 2015 Nov 27;7(12):6152-62. doi: 10.3390/v7122931.

Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.耐药性的进化后果：不同靶点和生物的共同原则。

Nat Rev Genet. 2015 Aug;16(8):459-71. doi: 10.1038/nrg3922. Epub 2015 Jul 7.

Fluorometric assay for phenotypic differentiation of drug-resistant HIV mutants.用于耐药性HIV突变体表型分化的荧光测定法。

Sci Rep. 2015 May 19;5:10323. doi: 10.1038/srep10323.

A system for the continuous directed evolution of proteases rapidly reveals drug-resistance mutations.一种用于蛋白酶连续定向进化的系统能快速揭示耐药性突变。

Nat Commun. 2014 Oct 30;5:5352. doi: 10.1038/ncomms6352.

Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.沙奎那韦抑制与 HIV-1 感染建立相关的早期事件：蛋白酶抑制剂在预防中的潜在作用。

Antimicrob Agents Chemother. 2012 Aug;56(8):4381-90. doi: 10.1128/AAC.00399-12. Epub 2012 Jun 4.

Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing.人类免疫缺陷病毒 1 型蛋白酶抑制剂对 Gag-Pol 多蛋白加工中初始自切割的活性。

Antimicrob Agents Chemother. 2012 Jul;56(7):3620-8. doi: 10.1128/AAC.00055-12. Epub 2012 Apr 16.

HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements.带有 20 种突变的 HIV-1 蛋白酶通过协调的结构重排表现出对临床抑制剂的极端耐药性。

Biochemistry. 2012 Apr 3;51(13):2819-28. doi: 10.1021/bi2018317. Epub 2012 Mar 20.

Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction.新型荧光反应法选择性、简便地测定人免疫缺陷病毒蛋白酶活性。

Anal Biochem. 2010 Feb 15;397(2):197-201. doi: 10.1016/j.ab.2009.10.030. Epub 2009 Oct 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验